Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
CSE:ZEAL
Watchlist
Price: 550.5 DKK 3.19% Market Closed
Market Cap: 39.1B DKK

EV/S
Enterprise Value to Sales

495.2
Current
95
Median
7.3
Industry
Higher than median
Higher than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
495.2
=
Enterprise Value
31B DKK
/
Revenue
62.7m DKK

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
26.8
2-Years Forward
EV/S
13
3-Years Forward
EV/S
17.5